Corneal disease in vernal keratoconjunctivitis and atopic keratoconjunctivitis currently requires aggressive treatment with topical steroids. In the future, better identification of the ...

Imagine if treatment for your eye condition was tailored to your individual ... The disease affects 1 in 25 Australians over ...

Glaukos (GKOS) announced the submission of its New Drug Application NDA to the U.S. Food and Drug Administration FDA or Epioxa or Epi-on, its ...

The Global Market for Corneal Ulcer Treatment Is Forecasted to Grow from USD 964.4 Million in 2024 To USD 1,601.1 Million by ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ...

From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments.

The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has ...

Medscape spoke with CDC’s Tim Uyeki about the rise in human H5N1 bird flu cases and Cara Drehoff about the response to a cluster of cases in Colorado poultry workers. Be Alert for Conjunctivitis ...

Future Market Insights (FMI) has unveiled a compelling new report forecasting significant expansion in the global fuchs ...

The corneal transplant market was projected to attain US$ 444.3 million in 2023. It is likely to garner a 5.6% CAGR from 2024 ...

A groundbreaking clinical trial in Japan has achieved a significant breakthrough in stem cell therapy, improving vision for three individuals with severe corneal damage due to limbal stem cell ...